Assignee
RESQ Pharmaceuticals LLC
US·5 granted patents·1 pending application·7 citations·filing 2020–2025
Top patents by PatentIndex Score
6 records- 0192US12329731B2Methods and compositions for treating edema refractory to oral diureticsRESQ Pharmaceuticals LLC·Filed 2024·Granted Jun 17, 2025·1 cites·20 claims
- 0292US12150923B2Methods and compositions for treating edema refractory to oral diureticsRESQ Pharmaceuticals LLC·Filed 2022·Granted Nov 26, 2024·2 cites·15 claims
- 0390US11260038B1Methods and compositions for treating edema refractory to oral diureticsRESQ Pharmaceuticals LLC·Filed 2021·Granted Mar 1, 2022·2 cites·30 claims
- 0489US11123319B2Methods and compositions for treating edema refractory to oral diureticsRESQ Pharmaceuticals LLC·Filed 2020·Granted Sep 21, 2021·2 cites·12 claims
- 0581US12558330B2Methods and compositions for treating edema refractory to oral diureticsRESQ Pharmaceuticals LLC·Filed 2025·Granted Feb 24, 2026·0 cites·10 claims
- 0658US2024285566A1Subcutaneous formulation and methods for treating edema refractory to oral diureticsRESQ Pharmaceuticals LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RESQ Pharmaceuticals LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →